W9114F-19-Q-0014-0001.pdf

W40M RHCO USAHCA EUROPE

REGIONAL HEALTH CONTR OFC EUROPE

POC: DOMENICO MADDALONI

CMR 402

APO AE 09180

0011289417

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER (Type or print)

30-105-04EXCEPTION TO SF 30

APPROVED BY OIRM 11-84

STANDARD FORM 30 (Rev. 10-83) Prescribed by GSA

FAR (48 CFR) 53.243

The purpose of this Amendment is to provide Questions and Answ ers (Q&A) to prospective vendors.

1. CONTRACT ID CODE PAGE OF PAGES

J 1 3

16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

16C. DATE SIGNED

BY 08-Feb-2019

16B. UNITED STATES OF AMERICA15C. DATE SIGNED15B. CONTRACTOR/OFFEROR

(Signature of Contracting Officer)(Signature of person authorized to sign)

8. NAME AND ADDRESS OF CONTRACTOR (No., Street, County, State and Zip Code) X W9114F19Q0014

X 9B. DATED (SEE ITEM 11)

08-Feb-2019

10B. DATED (SEE ITEM 13)

9A. AMENDMENT OF SOLICITATION NO.

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

X The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offer is extended, X is not extended.

Offer must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended by one of the following methods:

(a) By completing Items 8 and 15, and returning 1 copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted;

or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN

REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

12. ACCOUNTING AND APPROPRIATION DATA (If required)

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE

CONTRACT ORDER NO. IN ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(B).

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority)

E. IMPORTANT: Contractor is not, is required to sign this document and return copies to the issuing office.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

10A. MOD. OF CONTRACT/ORDER NO.

2. AMENDMENT/MODIFICATION NO. 5. PROJECT NO.(If applicable)

6. ISSUED BY

3. EFFECTIVE DATE

08-Feb-2019

CODE

W40M RHCO USAHCA EUROPE

REGIONAL HEALTH CONTR OFC EUROPE

CMR 402

APO AE 09180

W9114F 7. ADMINISTERED BY (If other than item 6)

4. REQUISITION/PURCHASE REQ. NO.

CODE W9114F

FACILITY CODECODE

EMAIL:TEL:

W9114F19Q0014

SECTION SF 30 BLOCK 14 CONTINUATION PAGE

SUMMARY OF CHANGES

SECTION SF 30 - BLOCK 14 CONTINUATION PAGE

The following have been added by full text:

IFC 0001

Joint Commission (TJC) Pre-Survey Assessment Visit (PSAV) to LRMC Healthcare Facilities

Questions Responses

1. The Scope of Work states that the Pre-Survey Assessment Visit (PSAV) is to occur during the week of 3 March thru 8 March 2019. Given a Response Date of 22 February and given the time allowed for the contract to be awarded, can this date of the PSAV be moved back to April or May so that we have adequate time to schedule our best team.

1-A) Period of Performance may be moved to April but it is preferred for the pre-survey to be complete no later than 19 April 2019.

2. The survey team shall consist of five (5) members, to include the following survey specialties: 1x Medical Provider, 2x Registered Nurses, 1x Behavioral Health Specialist, and 1x Ambulatory Care Specialist. Just to confirm, does the organization not want a Life Safety Code Specialist to participate in this PSAV?

2-A) LRMC has a contract with a consulting service focusing primarily on Environment of Care and Life Safety that does yearly inspections and workshops. Though we realize the value of this aspect of the accreditation manual it does not need to be the focus of the pre survey.

3. Paragraph 1.2. states that LRMC is currently surveyed under TJC Comprehensive Accreditation Manual for Ambulatory and Behavioral Health and PCMH certification.

According to the Joint Commission website, LRMC is accredited under the Hospital and Behavioral Health accreditation programs.

Please clarify as this distinction may impact the requested survey team complement (e.g., the addition of a Life Safety Specialist).

3-A) LRMC is accredited under the Hospital and Behavioral Health programs with certification in PCMH. PCMH certification was obtained in 2017 during the most recent survey.

4. TECHINICAL EXHIBIT # 1 - PLACE OF

PERFORMANCE provides for less than one full day (Day

5) to survey the hospital LRMC in Landstuhl. Please confirm that the intent of this PSAV is to focus on the performance of the AHCs in Baumholder, Kleber, Wiesbaden, Vicenza, and SHAPE -- and not the hospital.

4-A) Days 1 and 5 have a considerable amount of time allotted for LRMC, both Kleber and Baumholder require minimal travel time to each destination which is the intent of the afternoon. Though the focus is on the entire footprint, as an organization we spend less time evaluating the outpatient clinics and we received over 1/3 of our overall findings during the 2017 survey from our health clinic assets.

(End of Summary of Changes)

W9114F19Q0014